Medicare

DirectTrust(R) Announces Accreditation Criteria for New Emergency Preparedness Program for Public Review

Program consists of emergency preparedness policies, procedures, and guidance for several healthcare provider types; Industry feedback desired during 60-day public…

6 months ago

AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)

Additional clinical and real-world data from the industry’s largest and broadest amyloidosis pipeline will advance understanding of underlying mechanisms of…

6 months ago

Humana & Privia Medical Group–Georgia Partner with Bamboo Health to Earn KLAS Research Points of Light Award

Program increased visibility into patient whereabouts to improve Medicare Advantage patient outcomes and CMS Star RatingsLOUISVILLE, Ky. & BOSTON--(BUSINESS WIRE)--Lack…

6 months ago

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patientsManassas, Virginia--(Newsfile Corp. -…

6 months ago

Healthcare Research Publication Validates Real Time Medical Systems Impact on Improving Value-Based Care Outcomes with Post-Acute Analytics

Management in Healthcare conducts peer-review on how company’s post-acute analytics solution helped St. Joseph’s Health ACO achieve a 43% reduction…

6 months ago

Glenwood Regional Medical Center’s Status Restored by CMS and Fully Operational

State health officials determine facility is in substantial compliance and continuing to serve patients and community 24/7WEST MONROE, La.--(BUSINESS WIRE)--Glenwood…

6 months ago

Jaguar Health Reports First Quarter 2024 Financial Results

The combined net Q1 2024 revenue of approximately $2.4 million for prescription and non-prescription products increased approximately 20% versus net…

6 months ago

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today…

6 months ago